The Cervical DNA Dtex® Test
The Power of Genomics in the Early Detection of DNA Damage Caused by an HPV Infection
The Cervical DNA Dtex® Test identifies whether an HPV infection has damaged a patient’s cervical cells resulting in critical genomic changes to chromosomes 3q and 5p. This DNA damage has been shown to be present in over 95% of invasive cervical carcinomas (See Clinical Evidence). Armed with this knowledge, clinicians can make more informed medical decisions.
The Cervical DNA Dtex® Test is a proprietary test offered by NeoDiagnostix and is protected by 7 issued U.S. Patents.